Rubeola and Rubella: Two Distinct Viral Infections
Rubeola (measles) and rubella (German measles) are two completely different viral diseases that should not be confused—rubeola is a severe, potentially fatal infection with significant morbidity and mortality, while rubella is typically mild but poses devastating teratogenic risks during pregnancy. 1
Rubeola (Measles)
Clinical Characteristics and Severity
Rubeola is a serious disease with substantial mortality risk. The incubation period averages 10-12 days from exposure to prodrome and 14 days from exposure to rash (range: 7-18 days) 1.
Key morbidity and mortality features:
- Death occurs in 1-2 of every 1,000 reported cases in the United States 1
- Encephalitis develops in approximately 1 in 1,000 cases, often resulting in permanent brain damage and mental retardation 1
- Most common complications include diarrhea, middle ear infection, and bronchopneumonia 1
- Pneumonia and acute encephalitis are the leading causes of death 1
- In developing countries, case-fatality rates can reach 25% 1
High-risk populations for severe disease and death:
- Infants and young children
- Adults
- Immunocompromised persons (leukemia, lymphoma, HIV infection) 1
Long-term Complications
Subacute sclerosing panencephalitis (SSPE) is a rare but devastating degenerative disease of the central nervous system that appears years after measles infection. Widespread vaccination has essentially eliminated SSPE in the United States 1.
Pregnancy Complications
Measles during pregnancy increases rates of:
- Premature labor
- Spontaneous abortion
- Low birth weight 1
Rubella (German Measles)
Clinical Characteristics
Rubella is typically a mild, self-limited disease in children and adults 2, 3. The infection causes:
- Scarletiniform rash
- Cervical lymphadenopathy
- Mild constitutional symptoms 2
In older children and adults, particularly women, the disease may be more severe with:
- Joint involvement (polyarthralgia)
- Purpuric rash 2
The rash classically begins on the face, spreads cephalocaudally, becomes generalized within 24 hours, and disappears within 3 days 3.
The Critical Difference: Teratogenicity
The primary public health concern with rubella is its devastating teratogenic effects, not the acute illness itself 4.
Congenital Rubella Syndrome (CRS) occurs when infection happens during pregnancy:
- Infection during the first 12 weeks of pregnancy results in congenital infection and/or miscarriage in 80-90% of cases 2
- The classic triad of CRS includes:
Additional manifestations of CRS:
- Mental retardation
- Late complications: diabetes, thyroid disease, growth hormone deficiency, progressive panencephalitis 2
- Multiple organ system involvement with prolonged active infection and virus shedding in the postnatal period 2
Transmission
Rubella virus is spread via:
- Oral droplets
- Inhalation of virus-laden airborne droplets
- Direct contact with infected nasopharyngeal secretions 3
Critical infectious period: Virus is shed in the nasopharynx for approximately 7 days before and after the rash is visible. Patients with subclinical disease are also infectious 2.
Key Clinical Distinctions
| Feature | Rubeola (Measles) | Rubella (German Measles) |
|---|---|---|
| Severity | Severe, potentially fatal | Mild, self-limited |
| Mortality | 1-2 per 1,000 cases | Rare |
| Encephalitis | 1 per 1,000 cases | Rare |
| Pregnancy risk | Increased miscarriage, no congenital malformations | 80-90% fetal infection/miscarriage in first trimester |
| Congenital syndrome | No | Yes—devastating CRS |
Prevention Priority
Both diseases are vaccine-preventable through the MMR vaccine, which has reduced reported cases by more than 99% 1. The two-dose MMR schedule (first dose at 12-15 months, second dose at 4-6 years) is critical for preventing both diseases and, most importantly, preventing CRS 1.
All healthcare workers must have acceptable evidence of measles and rubella immunity 1.